Binding properties of sodium glucose co-transporter-2 inhibitor empagliflozin to human serum albumin: spectroscopic methods and computer simulations

References

• Abdelhameed, A. S., Alam, P., & Khan, R. H. (2016). Binding of Janus kinase inhibitor tofacitinib with human serum albumin: Multi-technique approach. Journal of Biomolecular Structure and Dynamics, 34(9), 2037–2044. doi: 10.1080/07391102.2015.1104522
   PubMed Web of Science ®Google Scholar
• Aghaee, E., Ghasemi, J. B., Manouchehri, F., & Balalaie, S. (2014). Combined docking, molecular dynamics simulations and spectroscopic studies for the rational design of a dipeptide ligand for affinity chromatography separation of human serum albumin. Journal of Molecular Modeling, 20(10), 2446. doi: 10.1007/s00894-014-2446-7
   PubMed Web of Science ®Google Scholar
• Barth, A. (2007). Infrared spectroscopy of proteins. Biochimica et Biophysica Acta (Bba) - Bioenergetics, 1767(9), 1073–1101. doi: 10.1016/j.bbabio.2007.06.004
   PubMed Web of Science ®Google Scholar
• Candelario, N., & Wykretowicz, J. (2016). The DKA that wasn't: A case of euglycemic diabetic ketoacidosis due to empagliflozin. Oxford Medical Case Reports, 2016(7), 144–146. doi: 10.1093/omcr/omw061
   PubMedGoogle Scholar
• Cheng, Z. (2012). Studies on the interaction between scopoletin and two serum albumins by spectroscopic methods. Journal of Luminescence, 132(10), 2719–2729. doi: 10.1016/j.jlumin.2012.05.032
   Web of Science ®Google Scholar
• Cheng, P. P., Silvester, D., Wang, G., Kalyuzhny, G., Douglas, A., & Murray, R. W. (2006). Dynamic and static quenching of fluorescence by 1–4 nm diameter gold monolayer-protected clusters. The Journal of Physical Chemistry B, 110(10), 4637. doi: 10.1021/jp057028n
   PubMed Web of Science ®Google Scholar
• Dangkoob, F., Housaindokht, M. R., Asoodeh, A., Rajabi, O., Rouhbakhsh Zaeri, Z., & Verdian Doghaei, A. (2015). Spectroscopic and molecular modeling study on the separate and simultaneous bindings of alprazolam and fluoxetine hydrochloride to human serum albumin (HSA): With the aim of the drug interactions probing. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 137, 1106–1119. doi: 10.1016/j.saa.2014.08.149
   PubMed Web of Science ®Google Scholar
• Fala, L. (2015). Jardiance (empagliflozin), an SGLT2 inhibitor, receives FDA approval for the treatment of patients with type 2 diabetes. American Health & Drug Benefits, 8(Spec Feature), 92.
   PubMedGoogle Scholar
• Gangadharan Komala, M., & Mather, A. (2014). Empagliflozin for the treatment of type 2 diabetes. Expert Review of Clinical Pharmacology, 7(3), 271–279. doi: 10.1586/17512433.2014.908703
   PubMed Web of Science ®Google Scholar
• Hans-Ulrich, H., Ludwig, M., Elke, S. B., Marc, W., Thomas, M., Broedl, U. C., & Woerle, H. J. (2014). Empagliflozin as add-on to metformin in patients with type 2 diabetes: A 24-week, randomized, double-blind, placebo-controlled trial. Diabetes Care, 36(11), 1650–1659. doi: 10.2337/dc13-2105
   Web of Science ®Google Scholar
• Hemmateenejad, B., Shamsipur, M., Samari, F., Khayamian, T., Ebrahimi, M., & Rezaei, Z. (2012). Combined fluorescence spectroscopy and molecular modeling studies on the interaction between harmalol and human serum albumin. Journal of Pharmaceutical and Biomedical Analysis, 67–68, 201–208. doi: 10.1016/j.jpba.2012.04.012
   PubMed Web of Science ®Google Scholar
• Hou, H., Qu, X., Li, Y., Kong, Y., Jia, B., Yao, X., & Jiang, B. (2015). Binding of citreoviridin to human serum albumin: Multispectroscopic and molecular docking. Biomed Research International, 2015, 1. doi: 10.1155/2015/162391
   Web of Science ®Google Scholar
• Huang, S., Qiu, H., Lu, S., Zhu, F., & Xiao, Q. (2015). Study on the molecular interaction of graphene quantum dots with human serum albumin: Combined spectroscopic and electrochemical approaches. Journal of Hazardous Materials, 285, 18–26. doi: 10.1016/j.jhazmat.2014.11.019
   PubMed Web of Science ®Google Scholar
• Jia, M., Yang, B., Li, Z., Shen, H., Song, X., & Gu, W. (2014). Computational analysis of functional single nucleotide polymorphisms associated with the CYP11B2 gene. Plos ONE, 9(8), e104311. doi: 10.1371/journal.pone.0104311
   PubMed Web of Science ®Google Scholar
• Khodaei, A., Bolandnazar, S., Valizadeh, H., Hasani, L., & Zakeri-Milani, P. (2016). Interactions between sirolimus and anti-inflammatory drugs: Competitive binding for human serum albumin. Advanced Pharmaceutical Bulletin, 6(2), 227–233. doi: 10.15171/apb.2016.031
   PubMed Web of Science ®Google Scholar
• Kragh-Hansen, U. (1988). Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands. Molecular Pharmacology, 34(2), 160–171.
   PubMed Web of Science ®Google Scholar
• Kumari, M., Maurya, J. K., Tasleem, M., Singh, P., & Patel, R. (2014). Probing HSA-ionic liquid interactions by spectroscopic and molecular docking methods. Journal of Photochemistry and Photobiology B: Biology, 138, 27–35. doi: 10.1016/j.jphotobiol.2014.05.009
   PubMed Web of Science ®Google Scholar
• Kumari, M., Singh, U. K., Singh, P., & Patel, R. (2017). Effect of N-butyl-N-methyl-morpholinium bromide ionic liquid on the conformation stability of human serum albumin. ChemistrySelect, 2(3), 1241–1249. doi: 10.1002/slct.201601477
   Web of Science ®Google Scholar
• Lakowicz, J. R. (2013). Principles of fluorescence spectroscopy. Berlin: Springer Science + Business Media.
   Google Scholar
• Li, X., Wang, G., Chen, D., & Lu, Y. (2015). beta-Carotene and astaxanthin with human and bovine serum albumins. Food Chemistry, 179, 213–221. doi: 10.1016/j.foodchem.2015.01.133
   PubMed Web of Science ®Google Scholar
• Liu, B.-S., Wang, J., Xue, C.-L., Yang, C., & Lü, Y.-K. (2012). Effects of synthetic food colorants on the interaction between norfloxacin and bovine serum albumin by fluorescence spectroscopy. Monatshefte Für Chemie – Chemical Monthly, 143(3), 401–408. doi: 10.1007/s00706-011-0593-4
   Google Scholar
• Maurya, N., Maurya, J. K., Singh, U. K., Dohare, R., Zafaryab, M., Moshahid Alam Rizvi, M., … Patel, R. (2019). In vitro cytotoxicity and interaction of noscapine with human serum albumin: Effect on structure and esterase activity of HSA. Molecular Pharmaceutics, 16(3), 952–966. doi: 10.1021/acs.molpharmaceut.8b00864
   PubMed Web of Science ®Google Scholar
• Maurya, J. K., Mir, M. U., Maurya, N., Dohare, N., Ali, A., & Patel, R. (2016). A spectroscopic and molecular dynamic approach on the interaction between ionic liquid type gemini surfactant and human serum albumin. Journal of Biomolecular Structure and Dynamics, 34(10), 2130–2145. doi: 10.1080/07391102.2015.1109552
   PubMed Web of Science ®Google Scholar
• Meti, M. D., Nandibewoor, S. T., Joshi, S. D., More, U. A., & Chimatadar, S. A. (2016). Binding interaction and conformational changes of human serum albumin with ranitidine studied by spectroscopic and time-resolved fluorescence methods. Journal of the Iranian Chemical Society, 13(7), 1325–1338. doi: 10.1007/s13738-016-0847-5
   Web of Science ®Google Scholar
• Mishra, B., Barik, A., Priyadarsini, K. I., & Mohan, H. (2005). Fluorescence spectroscopic studies on binding of a flavonoid antioxidant quercetin to serum albumins. Journal of Chemical Sciences, 117(6), 641–647. doi: 10.1007/BF02708293
   Web of Science ®Google Scholar
• Moghaddam, M. M., Pirouzi, M., Saberi, M. R., & Chamani, J. (2014). Comparison of the binding behavior of FCCP with HSA and HTF as determined by spectroscopic and molecular modeling techniques. Luminescence, 29(4), 314–331. doi: 10.1002/bio.2546
   PubMed Web of Science ®Google Scholar
• Parray, M. U D., Mir, M. U. H., Dohare, N., Maurya, N., Khan, A. B., Borse, M. S., & Patel, R. (2018). Effect of cationic gemini surfactant and its monomeric counterpart on the conformational stability and esterase activity of human serum albumin. Journal of Molecular Liquids, 260, 65–77. doi: 10.1016/j.molliq.2018.03.070
   Web of Science ®Google Scholar
• Rahman, M. H., Maruyama, T., Okada, T., Imai, T., & Otagiri, M. (1993). Study of interaction of carprofen and its enantiomers with human serum albumin—II: Stereoselective site-to-site displacement of carprofen by ibuprofen. Biochemical Pharmacology, 46(10), 1733–1740. doi: 10.1016/0006-2952(93)90577-J
   PubMed Web of Science ®Google Scholar
• Rahnama, E., Mahmoodian-Moghaddam, M., Khorsand-Ahmadi, S., Saberi, M. R., & Chamani, J. (2015). Binding site identification of metformin to human serum albumin and glycated human serum albumin by spectroscopic and molecular modeling techniques: A comparison study. Journal of Biomolecular Structure and Dynamics, 33(3), 513–533. doi: 10.1080/07391102.2014.893540
   PubMed Web of Science ®Google Scholar
• Ross, P. D., & Subramanian, S. (1981). Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry, 20(11), 3096–3102. doi: 10.1021/bi00514a017
   PubMed Web of Science ®Google Scholar
• Saeidifar, M., Mansouri-Torshizi, H., & Akbar Saboury, A. (2015). Biophysical study on the interaction between two palladium(II) complexes and human serum albumin by multispectroscopic methods. Journal of Luminescence, 167, 391–398. doi: 10.1016/j.jlumin.2015.07.016
   Web of Science ®Google Scholar
• Seedher, N., & Kanojia, M. (2008). Reversible binding of antidiabetic drugs, repaglinide and gliclazide, with human serum albumin. Chemical Biology & Drug Design, 72(4), 290–296. doi: 10.1111/j.1747-0285.2008.00704.x
   PubMed Web of Science ®Google Scholar
• Shahabadi, N., Khorshidi, A., & Moghadam, N. H. (2013). Study on the interaction of the epilepsy drug, zonisamide with human serum albumin (HSA) by spectroscopic and molecular docking techniques. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 114, 627–632. doi: 10.1016/j.saa.2013.05.092
   PubMed Web of Science ®Google Scholar
• Sinisi, V., Forzato, C., Cefarin, N., Navarini, L., & Berti, F. (2015). Interaction of chlorogenic acids and quinides from coffee with human serum albumin. Food Chemistry, 168, 332–340. doi: 10.1016/j.foodchem.2014.07.080
   PubMed Web of Science ®Google Scholar
• Sudlow, G., Birkett, D. J., & Wade, D. N. (1975). The characterization of two specific drug binding sites on human serum albumin. Molecular Pharmacology, 11, 824–832.
   PubMed Web of Science ®Google Scholar
• Sudlow, G., Birkett, D. J., & Wade, D. N. (1976). Further characterization of specific drug binding sites on human serum albumin. Molecular Pharmacology, 11(6), 1052–1061.
   Web of Science ®Google Scholar
• Sun, X., Bi, S., Wu, J., Zhao, R., Shao, D., & Song, Z. (2019). Multispectral and molecular docking investigations on the interaction of primethamine/trimethoprim with BSA/HSA. Journal of Biomolecular Structure and Dynamics, 1–9. doi: 10.1080/07391102.2019.1588785
   PubMed Web of Science ®Google Scholar
• Xu, Z.-Q., Yang, Q.-Q., Lan, J.-Y., Zhang, J.-Q., Peng, W., Jin, J.-C., … Liu, Y. (2016). Interactions between carbon nanodots with human serum albumin and gamma-globulins: The effects on the transportation function. Journal of Hazardous Materials, 301, 242–249. doi: 10.1016/j.jhazmat.2015.08.062
   PubMed Web of Science ®Google Scholar
• YASARA. Yet Another Scientific Artificial Reality Application: Molecular graphics, modeling and simulation program. Retrieved from http://www.yasara.org/
   Google Scholar
• Zhang, P., Li, Z., Wang, X., Shen, Z., Wang, Y., Yan, J., … Zhu, W. (2013). Study of the enantioselective interaction of diclofop and human serum albumin by spectroscopic and molecular modeling approaches in vitro. Chirality, 25(11), 719–725. doi: 10.1002/chir.22204
   PubMed Web of Science ®Google Scholar
• Zhao, L., Liu, J., Guo, R., Sun, Q., Yang, H., & Li, H. (2017). Investigating the interaction mechanism of fluorescent whitening agents to human serum albumin using saturation transfer difference-NMR, multi-spectroscopy, and docking studies. RSC Advances, 7(44), 27796–27806. doi: 10.1039/C7RA04008C
   Web of Science ®Google Scholar